Navigation Links
Toxic Chemicals in Many Couches Sold in U.S.: Report
Date:11/28/2012

WEDNESDAY, Nov. 28 (HealthDay News) -- Many couches sold in the United States contain toxic chemical flame retardants that have been linked with cancer, hormone disruption and neurological damage, according to a new study.

Researchers tested 102 couches and found that 85 percent of them were treated with chemical flame retardants that are known to be toxic or lack adequate information about their health effects.

Forty-one percent of the couches contained chlorinated Tris (TDCPP), a cancer-causing flame retardant removed from baby pajamas in the 1970s, and 17 percent contained the worldwide-banned chemical pentaBDE, the Duke University and University of California, Berkeley, researchers said.

They noted that many of the flame retardants found in the sofas are associated with hormone disruption, neurological and reproductive damage, and cancer in hundreds of animal studies and a number of human studies.

The chemicals continuously move out of furniture foam into house dust, which can then be consumed by pets and people, especially small children who are near floors and put their hands in their mouths, the researchers explained.

The study was published Nov. 28 in the journal Environmental Science & Technology.

"Hard to believe, 35 years after our research contributed to removing Tris from children's sleepwear, our current study suggests that more than a third of Americans' couches contain the same toxic flame retardant," study co-author Dr. Arlene Blum, executive director of the Green Science Policy Institute, said in a UC Berkeley news release. "And sadly enough, many Americans could now have increased cancer risks from the Tris in their furniture."

The Berkeley-based institute provides unbiased scientific data to government, industry and nongovernmental organizations.

In related news, another study published the same day found that most homes have levels of flame retardants that are
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Many home couches contain potentially toxic flame retardants
2. FEMA awards $1 Million to WPI to develop groundbreaking toxic gas sensors for firefighters
3. Combination peptide therapies might offer more effective, less toxic cancer treatment
4. Rejected drug may protect against toxic substance common to Alzheimers and Parkinsons diseases
5. New study suggests clinicians overlook alcohol problems if patients are not intoxicated
6. First-of-its-kind approach nanomedicine design effectively targets cancer with decreased toxicity
7. Turning off key piece of genetic coding eliminates toxic effect of statins, SLU research finds
8. Researchers will employ microscopic clay minerals to design more efficient and less toxic drugs
9. Local Woodinville Contractor, Washington State Kitchen and Bath, Combats Toxic Mold, Adhering to the Toughest Mold Protection Standards in the Nation with New Promotion
10. Chinese Drywall Complaint Center Now Demands Leadership From Obama & EPA, For Homeowners In Florida And In The US Southeast Stuck In Toxic Chinese Drywall Hell-Forward?
11. Toxic mercury, accumulating in the Arctic, springs from a hidden source
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Toxic Chemicals in Many Couches Sold in U.S.: Report
(Date:5/22/2015)... Combination therapy, or polytherapy, will ... obstructive pulmonary disorder (COPD) as the dominant companies ... as well as Germany’s Boehringer Ingelheim compete with ... will market payers, clinicians and patients be disposed ... completely new ones? , In spite of recently ...
(Date:5/22/2015)... “It’s like learning an new ... Vice President of Clinical Operations/Education and Training at ... impacts how care is coded and reimbursed.” , ... care reimbursement, operations and compliance consulting, as well ... launches a new series of day-long seminars on ...
(Date:5/22/2015)... Carnegie Science Center and ... partnership to develop BodyTech, a dynamic, three-pronged health and ... a new exhibit at the Science Center called BodyWorks, ... new traveling science show, Anatomy Adventure, which will hit ... Designed to explore a wide range of topics surrounding ...
(Date:5/22/2015)... Memorial Day weekend is typically considered the beginning ... some tips to help promote safe travel. , According to ... traffic fatalities this Memorial Day weekend. Amica is sharing the ... Association: , , Always wear a ... seatbelt, whether they’re driving or riding along as a passenger. ...
(Date:5/22/2015)... Power Systems is proud to announce the sponsorship of ... is in his second year of racing in the professional ... Fire Department in Missoula, MT. He entered the triathlon scene ... career, he has had 15 1st Place finishes. In his ... in all seven of his 2014 races, including two 2nd ...
Breaking Medicine News(10 mins):Health News:Chronic Obstructive Pulmonary Disorder Therapeutics Market Discussed in In-demand FirstWord Report Published at MarketPublishers.com 2Health News:Harmony Healthcare International Takes the Lead in Launching ICD-10 Coding Transition in Post-Acute Care 2Health News:Harmony Healthcare International Takes the Lead in Launching ICD-10 Coding Transition in Post-Acute Care 3Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 2Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 3Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 4Health News:Amica Has 4 Road Safety Tips for Memorial Day Weekend 2
... Poor sleep tied to quality of life, depression, study says ... common among elderly people who live in assisted living facilities, ... associated with declining quality of life and increased depression. , ... when they,re no longer able to live independently but do ...
... while longer-term risks are uncertain , FRIDAY, May 7 ... Gulf of Mexico and now some barrier islands off ... environment while posing risks to public health, experts say. ... headaches, nausea, coughing and throat irritation, according to the ...
... from a corticosteroid regimen have fewer cardiovascular events ... survival rates and reducing early mortality, according to ... of Cincinnati (UC) transplantation researchers. Researchers with ... medicine are presenting the work at the American ...
... explain different outcomes for women with similar-looking tumors, expert ... of breast cancer into subtypes can be achieved through ... U.S. researchers say. , They analyzed 32 gene expression ... and six classification models. , "We studied these models ...
... breast cancer , C.B. Agborsangaya, FINLAND, As women ... the incidence of pregnancy-associated breast cancer is expected ... p53 autoantibody-positive pregnant women may be useful in ... cancer. Abstract 92P: Post traumatic stress disorder ...
... a benign tumor of mesenchymal origin which is mostly ... 2/3 of small bowel occlusion caused by up to ... frequent benign tumor that causes invagination in its submucous ... form. However, multiple lipomas within the intestinal duplication canal ...
Cached Medicine News:Health News:Sleepless Nights Plague Assisted Living Residents 2Health News:Gulf Oil Spill Could Threaten Human Health 2Health News:Gulf Oil Spill Could Threaten Human Health 3Health News:Study finds post-transplant patients off steroids have fewer cardiovascular events 2Health News:Study finds post-transplant patients off steroids have fewer cardiovascular events 3Health News:Simple Test May Identify Breast Cancer Subtypes 2Health News:Interesting stories at the IMPAKT Breast Cancer Conference 2Health News:Interesting stories at the IMPAKT Breast Cancer Conference 3
(Date:5/22/2015)... May 22, 2015 The leading companies ... billion global cardiac rhythm management device market dominate ... that Medtronic, St. Jude Medical, Boston Scientific and ... this market segment. The healthcare market research publisher,s ... uses 2015 as a base year, providing forecasts ...
(Date:5/22/2015)... , May 22, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: ... protection, repair and regeneration, today announced that J.J. ... to present a corporate overview at two upcoming investor ... the SeeThruEquity 4 th Annual Microcap Conference on ... City at 11:00 am EDT.  A webcast ...
(Date:5/22/2015)... KING OF PRUSSIA, Pa. , May 22, 2015 ... CSL Behring its 2015 Corporate Leadership Award as ... science and improving the care of the bleeding disorders community.  ... and Managing Director, CSL Limited, during the NHF Annual Spring ... May 21. "The National Hemophilia Foundation is dedicated ...
Breaking Medicine Technology:Kalorama: Top Companies Dominate Cardiac Defibrillator Market 2Kalorama: Top Companies Dominate Cardiac Defibrillator Market 3Kalorama: Top Companies Dominate Cardiac Defibrillator Market 4RegeneRx to Present at 2 Investor Conferences 2RegeneRx to Present at 2 Investor Conferences 3National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 2National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 3National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 4
... July 29 Micromet, Inc.,(Nasdaq: MITI ), ... treatment of cancer, inflammation and autoimmune,diseases, today announced ... audio,webcast on Thursday, August 7, 2008, at 9:00 ... discuss its second quarter 2008 financial,results. Micromet anticipates ...
... July 28 BioCryst,Pharmaceuticals, Inc. (Nasdaq: BCRX ... study of intravenous (i.v.) peramivir administered via a ... treatment of seasonal,influenza. The trial, conducted by BioCryst,s ... primary endpoint of improvement in the median time ...
Cached Medicine Technology:Micromet, Inc. to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results 2Micromet, Inc. to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results 3BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting 2BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting 3BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting 4BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting 5
... its synthetic bone substitute Ossatura. Developed at Isotis, ... material, i.e. a material that is designed to ... the musculo-skeletal system that results in bone growth. ... and reduces in part or entirely the need ...
Schuknecht-Weitlaner retractor, sharp, angled arms....
Beckman-Weitlaner retractor, blunt, with hinged arms, 6 1/2"....
Daubenspeck sharp curette, 8....
Medicine Products: